Amphenol Shares Jump 7% in a Month: Should Investors Buy the Stock?

Amphenol (APH) shares have risen 7% in the past month, outperforming its peers and the broader Technology sector. This growth is attributed to a diversified business model and strategic acquisitions, including CIT, Andrew, and LifeSync, which are expected to bolster earnings. The company's Q2 2025 guidance projects EPS between $0.64-$0.66, representing a 45-50% year-over-year increase, and sales are anticipated to grow 36-39%; however, the stock's forward P/E of 33.21X indicates a premium valuation compared to its competitors.

Analysis

Amphenol Corporation (APH) has demonstrated robust performance, with its shares appreciating 7% over the past month, significantly outperforming the Zacks Computer & Technology sector's 2.5% gain and key peers like CommScope, TE Connectivity, and Sensata Technologies. This outperformance is underpinned by a diversified business model, which mitigates end-market volatility, and a strong portfolio of interconnect and sensor products. The company's stock is currently trading above its 50-day and 200-day moving averages, indicating a bullish technical trend. Strategically, Amphenol is benefiting from increased spending on next-generation defense technologies, strong demand in commercial aerospace, and the burgeoning AI and machine learning-driven IT datacom market. Acquisitions are a core component of Amphenol's growth strategy, with buyouts contributing 8% to 2024 revenues; recent acquisitions such as CIT, Lutze, CommScope’s Andrew business, and LifeSync are set to enhance its offerings across industrial, communications, and medical markets. Specifically, the Andrew acquisition is projected to add approximately 9 cents to 2025 earnings. Amphenol has issued positive guidance for the second quarter of 2025, with earnings per share expected between $0.64 and $0.66 (a 45-50% year-over-year increase) and sales anticipated between $4.90 billion and $5.0 billion (a 36-39% year-over-year increase). The Zacks Consensus Estimate for Q2 2025 EPS stands at $0.66, reflecting a 53.49% YoY growth, and the full-year 2025 EPS estimate is $2.68, indicating a 41.8% YoY growth, with both estimates having been revised upwards recently. Despite these strong fundamentals and a Zacks Rank #1 (Strong Buy), Amphenol shares trade at a premium, with a forward 12-month P/E ratio of 33.21X, compared to the sector average of 26.06X and significantly above its peers, a valuation the article suggests is justified by its diversified model and strong portfolio.

Key Decisions for Investors

• Investors may find Amphenol an attractive opportunity given its strong Q2 2025 guidance, projecting 45-50% year-over-year EPS growth, and its consistent outperformance, although the premium valuation with a forward P/E of 33.21X requires careful consideration relative to individual risk appetite.
• The company's aggressive M&A strategy, with recent acquisitions like Andrew expected to contribute 9 cents to 2025 EPS, warrants monitoring for successful integration and synergy realization to sustain the growth trajectory and justify the current stock premium.
• Consider the secular growth drivers in Amphenol's key end markets, such as AI/ML in IT datacom, next-generation defense, and commercial aerospace, as these are critical to maintaining the high-single-digit sequential sales growth anticipated for Q2 2025 and the projected 41.8% full-year 2025 earnings growth.